Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C2H4NO2.Mn |
| Molecular Weight | 203.0554 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Mn++].NCC([O-])=O.NCC([O-])=O
InChI
InChIKey=JNMKPXXKHWQWFB-UHFFFAOYSA-L
InChI=1S/2C2H5NO2.Mn/c2*3-1-2(4)5;/h2*1,3H2,(H,4,5);/q;;+2/p-2
MANGANESE GLYCINATE is composed of trace mineral manganese and an amino acid, glycine. It is easily absorbable. It helps the body in a variety of ways including formation of clotting factors, connective tissue sex hormones and bones. It helps in the absorption of calcium and metabolism of carbohydrate as well as fat. It plays an important role for normal nerve and brain function. Moreover, it is a component of the enzyme, superoxide dismutase which helps fighting free radicals. Decreased manganese level can cause infertility, seizures, weakness and bone malformation. Manganese Glycinate (Mn(glycinate)2) has application as a contrast enhancement agent for magnetic resonance imaging in the heart. Toxicity, which is primarily due to the action of manganese as a calcium channel
blocker with effects on muscle electrophysiology and contractility, has limited the use of manganese salts as paramagnetic contrast agents. Mn(glycinate)2 exerts its negative inotropic effect, at least partially, by interfering with the function of the L-type Ca channels at high concentrations.
Approval Year
Sample Use Guides
As a dietary supplement for adults, take one tablet (8 mg Manganese
as manganese glycinate amino acid chelate) daily, preferably with a meal or as directed by a healthcare practitioner.
Route of Administration:
Oral
Manganese Glycinate (Mn(glycinate)2) decreased amplitude of contraction in chick atrial cells from embryos 14 days in ovo with complete inhibition of beating at 1 mM and half-maximal effect at 0.1 mM. Under control conditions, Bay K 8644, a Ca channel activator increased amplitude of contraction by 86% with a half maximal effect at 3.2 x 10(-7) M. In the presence of 0.025 mM Mn(glycinate)2, a concentration which had no effect on the amplitude of contraction, the maximum response to Bay K 8644 was decreased to 31%. Mn(glycinate)2 had no effect on the EC50 for the response to Bay K 8644, 1.7 +/- 0.1 x 10(-9) M (S.E.M., n = 4) in control cells compared to 2.2 +/- 0.4 x 10(-9) M (S.E.M., n = 4) in cells incubated with Mn(glycinate)2.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
151440
Created by
admin on Sat Dec 16 08:31:36 GMT 2023 , Edited by admin on Sat Dec 16 08:31:36 GMT 2023
|
PRIMARY | |||
|
DTXSID30329019
Created by
admin on Sat Dec 16 08:31:36 GMT 2023 , Edited by admin on Sat Dec 16 08:31:36 GMT 2023
|
PRIMARY | |||
|
B49L2D4K1D
Created by
admin on Sat Dec 16 08:31:36 GMT 2023 , Edited by admin on Sat Dec 16 08:31:36 GMT 2023
|
PRIMARY | |||
|
14281-77-7
Created by
admin on Sat Dec 16 08:31:36 GMT 2023 , Edited by admin on Sat Dec 16 08:31:36 GMT 2023
|
PRIMARY | |||
|
300000026975
Created by
admin on Sat Dec 16 08:31:36 GMT 2023 , Edited by admin on Sat Dec 16 08:31:36 GMT 2023
|
PRIMARY | |||
|
81420
Created by
admin on Sat Dec 16 08:31:36 GMT 2023 , Edited by admin on Sat Dec 16 08:31:36 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
